1
|
Leane M, Pitt K, Reynolds G, Tantuccio A, Moreton C, Crean A, Kleinebudde P, Carlin B, Gamble J, Gamlen M, Stone E, Kuentz M, Gururajan B, Khimyak YZ, Van Snick B, Andersen S, Misic Z, Peter S, Sheehan S. Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture. Pharm Dev Technol 2024; 29:395-414. [PMID: 38618690 DOI: 10.1080/10837450.2024.2342953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2024] [Accepted: 04/10/2024] [Indexed: 04/16/2024]
Abstract
The MCS initiative was first introduced in 2013. Since then, two MCS papers have been published: the first proposing a structured approach to consider the impact of drug substance physical properties on manufacturability and the second outlining real world examples of MCS principles. By 2023, both publications had been extensively cited by over 240 publications. This article firstly reviews this citing work and considers how the MCS concepts have been received and are being applied. Secondly, we will extend the MCS framework to continuous manufacture. The review structure follows the flow of drug product development focussing first on optimisation of API properties. The exploitation of links between API particle properties and manufacturability using large datasets seems particularly promising. Subsequently, applications of the MCS for formulation design include a detailed look at the impact of percolation threshold, the role of excipients and how other classification systems can be of assistance. The final review section focusses on manufacturing process development, covering the impact of strain rate sensitivity and modelling applications. The second part of the paper focuses on continuous processing proposing a parallel MCS framework alongside the existing batch manufacturing guidance. Specifically, we propose that continuous direct compression can accommodate a wider range of API properties compared to its batch equivalent.
Collapse
Affiliation(s)
- Michael Leane
- Drug Product Development, Bristol Myers Squibb, Moreton, UK
| | - Kendal Pitt
- Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - Gavin Reynolds
- Oral Product Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK
| | - Anthony Tantuccio
- Technology Intensification, Hovione LLC, East Windsor, New Jersey, USA
| | | | - Abina Crean
- SSPC, the SFI Centre for Pharmaceutical Research, School of Pharmacy, University College Cork, Cork, Ireland
| | - Peter Kleinebudde
- Faculty of Mathematics and Natural Sciences, Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | - Brian Carlin
- Owner, Carlin Pharma Consulting, Lawrenceville, New Jersey, USA
| | - John Gamble
- Drug Product Development, Bristol Myers Squibb, Moreton, UK
| | - Michael Gamlen
- Chief Scientific Officer, Gamlen Tableting Ltd, Heanor, UK
| | - Elaine Stone
- Consultant, Stonepharma Ltd. ATIC, Loughborough, UK
| | - Martin Kuentz
- Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences FHNW, Muttenz, Switzerland
| | - Bindhu Gururajan
- Pharmaceutical Development, Novartis Pharma AG, Basel, Switzerland
| | - Yaroslav Z Khimyak
- School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK
| | - Bernd Van Snick
- Oral Solids Development, Drug Product Development, JnJ Innovative Medicine, Beerse, Belgium
| | - Sune Andersen
- Oral Solids Development, Drug Product Development, JnJ Innovative Medicine, Beerse, Belgium
| | - Zdravka Misic
- Innovation Research and Development, dsm-firmenich, Kaiseraugst, Switzerland
| | - Stefanie Peter
- Research and Development Division, F. Hoffmann-La Roche AG, Basel, Switzerland
| | - Stephen Sheehan
- External Development and Manufacturing, Alkermes Pharma Ireland Limited, Dublin 4, Ireland
| |
Collapse
|
2
|
Wünsch I, Henrik Finke J, John E, Juhnke M, Kwade A. Influence of the drug deformation behaviour on the predictability of compressibility and compactibility of binary mixtures. Int J Pharm 2022; 626:122117. [PMID: 35985527 DOI: 10.1016/j.ijpharm.2022.122117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Revised: 08/06/2022] [Accepted: 08/11/2022] [Indexed: 10/15/2022]
Abstract
Various studies investigate the predictability of the compressibility and compactibility of tablet formulations based on the behaviour of the pure materials. However, these studies are limited to a few materials so far probably because of the complexity of the powder compaction process. One approach preventing the excessive increase in complexity is the extension of the investigations from pure materials to binary powder mixtures. The focus of this study is on the predictability of the compressibility and compactibility of binary mixtures consisting of an active pharmaceutical ingredient (API) and the excipient microcrystalline cellulose. Three APIs with markedly different deformation behaviour were used. The API concentration and type are systematically varied. For all three material combinations it is found that the in-die compressibility of the binary mixtures can be precisely predicted based on the characteristic compression parameters of the raw materials using the extended in-die compression function in combination with a volume-based linear mixing rule. Since the tablet porosity (out-of-die) also follows a linear mixing rule, the predictability can be further extended using the method of Katz et al. In contrast, the influence of the API concentration on compactibility or rather on tablet tensile strength is non-linear and strongly dependent on the deformation behaviour of the API, making the predictability more difficult. Neither the approach of Reynolds et al. nor this of Kuentz and Leuenberger are able to predict the compactibility when clear deviations from a linear mixing rule appear.
Collapse
Affiliation(s)
- Isabell Wünsch
- Technische Universität Braunschweig, Institute for Particle Technology, Volkmaroder Straße 5, 38104, Braunschweig, Germany; Technische Universität Braunschweig, Center of Pharmaceutical Engineering (PVZ), Franz-Liszt-Straße 35A, 38106 Braunschweig, Germany
| | - Jan Henrik Finke
- Technische Universität Braunschweig, Institute for Particle Technology, Volkmaroder Straße 5, 38104, Braunschweig, Germany; Technische Universität Braunschweig, Center of Pharmaceutical Engineering (PVZ), Franz-Liszt-Straße 35A, 38106 Braunschweig, Germany
| | | | | | - Arno Kwade
- Technische Universität Braunschweig, Institute for Particle Technology, Volkmaroder Straße 5, 38104, Braunschweig, Germany; Technische Universität Braunschweig, Center of Pharmaceutical Engineering (PVZ), Franz-Liszt-Straße 35A, 38106 Braunschweig, Germany
| |
Collapse
|
3
|
Magalhães APDSPA, Toma HK, do Carmo FA, Mansur CRE. Development of purified cashew gum mucoadhesive buccal tablets containing nystatin for treatment of oral candidiasis. Drug Dev Ind Pharm 2021; 47:825-837. [PMID: 34033502 DOI: 10.1080/03639045.2021.1934868] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
OBJECTIVE The objective of this work was to prepare mucoadhesive buccal tablets containing nystatin and purified cashew gum for the treatment of oral candidiasis. SIGNIFICANCE Mucoadhesive buccal tablets containing the drug nystatin are an alternative to oral suspensions, which cause low therapeutic adherence to the treatment of oral candidiasis. Purified cashew gum has been studied as a diluent and mucoadhesive agent in tablets. METHODS Two batches of mucoadhesive tablets were produced, MT1 and MT 2, containing purified cashew gum, nystatin (500,000 IU), flavoring agent and with or without the presence of lubricant agent. The average weight, mechanical properties, dose uniformity, drug release profile, mucoadhesive properties and antimicrobial activity against Candida albicans were evaluated. RESULTS Tablets presented average weight of 329.1 ± 3.1 mg (MT1) and 334.6 ± 1.5 mg (MT2), hardness of 9.8 ± 0.8 KgF (MT1) and 8.3 ± 0.4 KgF (MT2), friability of 0.2% (MT1 and MT2), and dose uniformity of 102.20 ± 1.17% (MT1) and 99.06 ± 7.40% (MT2). MT1 and MT2 were able to swell, erode, release the drug and remain adhered to the pig's cheek up to 3 h for batch MT1 and 4 h for batch MT2, and the amount of nystatin released since the beginning of the test in both batches was sufficient to inhibit the growth of the fungus. CONCLUSIONS Therefore, the proposed formulation proved to be very promising and met all the studied criteria, showing to be ideal for the treatment of oral candidiasis.
Collapse
Affiliation(s)
| | - Helena Keiko Toma
- Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - Claudia Regina Elias Mansur
- Institute of Macromolecules, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.,Program of Materials Engineering and Metallurgy, Technology Center, Alberto Luiz Institute of Coimbra, Post-Graduation and Engineering Research - COPPE, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| |
Collapse
|
4
|
Hirschberg C, Sun CC, Risbo J, Rantanen J. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques. J Pharm Sci 2019; 108:2613-2620. [DOI: 10.1016/j.xphs.2019.03.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Revised: 02/28/2019] [Accepted: 03/01/2019] [Indexed: 10/27/2022]
|
5
|
Schaller BE, Moroney KM, Castro-Dominguez B, Cronin P, Belen-Girona J, Ruane P, Croker DM, Walker GM. Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study. Int J Pharm 2019; 566:615-630. [PMID: 31158454 DOI: 10.1016/j.ijpharm.2019.05.073] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2019] [Revised: 05/13/2019] [Accepted: 05/30/2019] [Indexed: 10/26/2022]
Abstract
In this work, the transfer of oral solid dosage forms, currently manufactured via wet granulation, to a continuous direct compression process was considered. Two main challenges were addressed: (1) a poorly flowing API (Canagliflozin) and (2) high drug loading (51 wt%). A scientific approach was utilised for formulation development, targeting flow and compaction behaviour suitable for manufacturing scale. This was achieved through systematic screening of excipients to identify feasible formulations. Targeted design of experiments based on factors such as formulation mixture and processing parameters were utilised to investigate key responses for tablet properties, flow and compaction behaviour. Flow behaviour was primarily evaluated from percentage compressibility and shear cell testing on a powder flow rheometer (FT4). The compaction behaviour was studied using a compaction simulator (Gamlen). The relationships between tablet porosity, tensile strength and compaction pressure were used to evaluate tabletability, compactibility and compressibility to assess scale-up. The success of this design procedure is illustrated by scaling up from the compaction simulator to a Riva Piccola rotary tablet press, while maintaining critical quality attributes (CQAs). Compactibility was identified as a suitable scale-up relationship. The developed procedure should allow accelerated development of formulations for continuous direct compression.
Collapse
Affiliation(s)
- Barbara E Schaller
- Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland.
| | - Kevin M Moroney
- Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland; MACSI, Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland
| | | | - Patrick Cronin
- Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
| | - Jorge Belen-Girona
- Johnson & Johnson Supply Chain, Product Supply - Manufacturing Engineering and Technology, USA
| | - Patrick Ruane
- Johnson & Johnson Supply Chain, Product Supply - Manufacturing Engineering and Technology, USA
| | - Denise M Croker
- Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
| | - Gavin M Walker
- Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland
| |
Collapse
|
6
|
Chen H, Aburub A, Sun CC. Direct Compression Tablet Containing 99% Active Ingredient—A Tale of Spherical Crystallization. J Pharm Sci 2019; 108:1396-1400. [DOI: 10.1016/j.xphs.2018.11.015] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Revised: 10/29/2018] [Accepted: 11/07/2018] [Indexed: 11/27/2022]
|
7
|
Sebastian Escotet-Espinoza M, Moghtadernejad S, Oka S, Wang Y, Roman-Ospino A, Schäfer E, Cappuyns P, Van Assche I, Futran M, Ierapetritou M, Muzzio F. Effect of tracer material properties on the residence time distribution (RTD) of continuous powder blending operations. Part I of II: Experimental evaluation. POWDER TECHNOL 2019. [DOI: 10.1016/j.powtec.2018.10.040] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Leane M, Pitt K, Reynolds GK, Dawson N, Ziegler I, Szepes A, Crean AM, Dall Agnol R, The Manufacturing Classification System McS Working Group. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing. Pharm Dev Technol 2018; 23:964-977. [PMID: 30320539 DOI: 10.1080/10837450.2018.1534863] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Following the first Manufacturing Classification System (MCS) paper, the team conducted surveys to establish which active pharmaceutical ingredient (API) properties were important when selecting or modifying materials to enable an efficient and robust pharmaceutical manufacturing process. The most commonly identified factors were (1) API particle size: small particle sizes are known to increase risk of processing issues; (2) Drug loading in the formulation: high drug loadings allow less opportunity to mitigate poor API properties through the use of excipients. The next step was to establish linkages with process decisions by identifying publicly-available proxies for these important parameters: dose (in place of drug loading) and BCS class (in place of particle size). Poorly-soluble API were seen as more likely to have controlled (smaller) particle size than more highly soluble API. Analysis of 435 regulatory filings revealed that higher doses and more poorly-soluble API was associated with more complex processing routes. Replacing the proxy factors with the original parameters should give the opportunity to demonstrate stronger trends. This assumption was tested by accessing a dataset relating to commercial tablet products. This showed that, for dry processes, a larger particle size was associated with higher achievable drug loading as determined by percolation threshold.
Collapse
Affiliation(s)
- Michael Leane
- a Drug Product Science & Technology (DPST), Bristol-Myers Squibb , Moreton , UK
| | - Kendal Pitt
- b Global Manufacturing and Supply, GlaxoSmithKline , Ware , UK
| | | | - Neil Dawson
- d Global Research and Development, Pfizer , Sandwich , UK
| | - Iris Ziegler
- e Corden Pharma International GmbH , Plankstadt , Germany
| | - Aniko Szepes
- f Research and Development Division, F. Hoffmann-La Roche AG , Basel , Switzerland
| | - Abina M Crean
- g Pharmaceutical Manufacturing Technology Centre, School of Pharmacy , University College Cork - National University of Ireland , Cork , Ireland.,h Synthesis and Solid State Pharmaceutical Centre, School of Pharmacy , University College Cork - National University of Ireland , Cork , Ireland
| | - Rafaela Dall Agnol
- i Curso de Farmácia, Centro de Ciências Biológicas e da Saúde , Universidade de Caxias do Sul , Caxias do Sul , Brazil
| | | |
Collapse
|
9
|
Optimization of the Critical Parameters of the Spherical Agglomeration Crystallization Method by the Application of the Quality by Design Approach. MATERIALS 2018; 11:ma11040635. [PMID: 29677152 PMCID: PMC5951519 DOI: 10.3390/ma11040635] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Revised: 04/12/2018] [Accepted: 04/18/2018] [Indexed: 12/04/2022]
Abstract
This research work presents the use of the Quality by Design (QbD) concept for optimization of the spherical agglomeration crystallization method in the case of the active agent, ambroxol hydrochloride (AMB HCl). AMB HCl spherical crystals were formulated by the spherical agglomeration method, which was applied as an antisolvent technique. Spherical crystals have good flowing properties, which makes the direct compression tableting method applicable. This means that the amount of additives used can be reduced and smaller tablets can be formed. For the risk assessment, LeanQbD Software was used. According to its results, four independent variables (mixing type and time, dT (temperature difference between solvent and antisolvent), and composition (solvent/antisolvent volume ratio)) and three dependent variables (mean particle size, aspect ratio, and roundness) were selected. Based on these, a 2–3 mixed-level factorial design was constructed, crystallization was accomplished, and the results were evaluated using Statistica for Windows 13 program. Product assay was performed and it was revealed that improvements in the mean particle size (from ~13 to ~200 µm), roundness (from ~2.4 to ~1.5), aspect ratio (from ~1.7 to ~1.4), and flow properties were observed while polymorphic transitions were avoided.
Collapse
|
10
|
Vasudevan KV, Osei-Yeboah F, Tran KK, Patience D, Irdam E, Kwok DI, Peterson ML. Crystallization of a Metastable Solvate and Impact of the Isolation Method on the Material Properties of the Anhydrous Product. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Kalyan V. Vasudevan
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Frederick Osei-Yeboah
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Kenny K. Tran
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Daniel Patience
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Erwin Irdam
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Daw-Iong Kwok
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Matthew L. Peterson
- Pharmaceutical Sciences, Engineering & Technology, Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States
| |
Collapse
|
11
|
Hayashi Y, Oishi T, Shirotori K, Marumo Y, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y. Modeling of quantitative relationships between physicochemical properties of active pharmaceutical ingredients and tensile strength of tablets using a boosted tree. Drug Dev Ind Pharm 2018; 44:1090-1098. [DOI: 10.1080/03639045.2018.1434195] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Yoshihiro Hayashi
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Japan
| | - Takuya Oishi
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Japan
| | - Kaede Shirotori
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Japan
| | - Yuki Marumo
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Japan
| | - Atsushi Kosugi
- Formulation Development Department, Development and Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., Namerikawa-shi, Japan
| | - Shungo Kumada
- Formulation Development Department, Development and Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., Namerikawa-shi, Japan
| | - Daijiro Hirai
- Formulation Development Department, Development and Planning Division, Nichi-Iko Pharmaceutical Co., Ltd., Namerikawa-shi, Japan
| | - Kozo Takayama
- Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan
| | - Yoshinori Onuki
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Japan
| |
Collapse
|
12
|
Markl D, Strobel A, Schlossnikl R, Bøtker J, Bawuah P, Ridgway C, Rantanen J, Rades T, Gane P, Peiponen KE, Zeitler JA. Characterisation of pore structures of pharmaceutical tablets: A review. Int J Pharm 2018; 538:188-214. [PMID: 29341913 DOI: 10.1016/j.ijpharm.2018.01.017] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Revised: 01/03/2018] [Accepted: 01/05/2018] [Indexed: 10/18/2022]
Abstract
Traditionally, the development of a new solid dosage form is formulation-driven and less focus is put on the design of a specific microstructure for the drug delivery system. However, the compaction process particularly impacts the microstructure, or more precisely, the pore architecture in a pharmaceutical tablet. Besides the formulation, the pore structure is a major contributor to the overall performance of oral solid dosage forms as it directly affects the liquid uptake rate, which is the very first step of the dissolution process. In future, additive manufacturing is a potential game changer to design the inner structures and realise a tailor-made pore structure. In pharmaceutical development the pore structure is most commonly only described by the total porosity of the tablet matrix. Yet it is of great importance to consider other parameters to fully resolve the interplay between microstructure and dosage form performance. Specifically, tortuosity, connectivity, as well as pore shape, size and orientation all impact the flow paths and play an important role in describing the fluid flow in a pharmaceutical tablet. This review presents the key properties of the pore structures in solid dosage forms and it discusses how to measure these properties. In particular, the principles, advantages and limitations of helium pycnometry, mercury porosimetry, terahertz time-domain spectroscopy, nuclear magnetic resonance and X-ray computed microtomography are discussed.
Collapse
Affiliation(s)
- Daniel Markl
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB3 0AS Cambridge, UK.
| | - Alexa Strobel
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB3 0AS Cambridge, UK
| | - Rüdiger Schlossnikl
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB3 0AS Cambridge, UK
| | - Johan Bøtker
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark
| | - Prince Bawuah
- School of Pharmacy, Promis Centre, University of Eastern Finland, P.O. Box 1617, FI-70211 Kuopio, Finland
| | - Cathy Ridgway
- Omya International AG, CH-4665 Oftringen, Switzerland
| | - Jukka Rantanen
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark
| | - Thomas Rades
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark
| | - Patrick Gane
- Omya International AG, CH-4665 Oftringen, Switzerland; School of Chemical Technology, Department of Bioproducts and Biosystems, Aalto University, FI-00076 Aalto, Helsinki, Finland
| | - Kai-Erik Peiponen
- Institute of Photonics, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, Finland
| | - J Axel Zeitler
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB3 0AS Cambridge, UK
| |
Collapse
|
13
|
Hayashi Y, Tsuji T, Shirotori K, Oishi T, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y. Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method. Int J Pharm 2017; 532:82-89. [PMID: 28859939 DOI: 10.1016/j.ijpharm.2017.08.111] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 08/07/2017] [Accepted: 08/23/2017] [Indexed: 10/19/2022]
Abstract
In this study, we evaluated the correlation between the response surfaces for the tablet characteristics of placebo and active pharmaceutical ingredient (API)-containing tablets. The quantities of lactose, cornstarch, and microcrystalline cellulose were chosen as the formulation factors. Ten tablet formulations were prepared. The tensile strength (TS) and disintegration time (DT) of tablets were measured as tablet characteristics. The response surfaces for TS and DT were estimated using a nonlinear response surface method incorporating multivariate spline interpolation, and were then compared with those of placebo tablets. A correlation was clearly observed for TS and DT of all APIs, although the value of the response surfaces for TS and DT was highly dependent on the type of API used. Based on this knowledge, the response surfaces for TS and DT of API-containing tablets were predicted from only two and four formulations using regression expression and placebo tablet data, respectively. The results from the evaluation of prediction accuracy showed that this method accurately predicted TS and DT, suggesting that it could construct a reliable response surface for TS and DT with a small number of samples. This technique assists in the effective estimation of the relationships between design variables and pharmaceutical responses during pharmaceutical development.
Collapse
Affiliation(s)
- Yoshihiro Hayashi
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan.
| | - Takahiro Tsuji
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan
| | - Kaede Shirotori
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan
| | - Takuya Oishi
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan
| | - Atsushi Kosugi
- Formulation Development Department, Development & Planning Division, Nichi-Oko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama, 936-0857, Japan
| | - Shungo Kumada
- Formulation Development Department, Development & Planning Division, Nichi-Oko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama, 936-0857, Japan
| | - Daijiro Hirai
- Formulation Development Department, Development & Planning Division, Nichi-Oko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa Namerikawa-shi, Toyama, 936-0857, Japan
| | - Kozo Takayama
- Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan
| | - Yoshinori Onuki
- Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan
| |
Collapse
|
14
|
Fang L, Yin X, Wu L, He Y, He Y, Qin W, Meng F, York P, Xu X, Zhang J. Classification of microcrystalline celluloses via structures of individual particles measured by synchrotron radiation X-ray micro-computed tomography. Int J Pharm 2017; 531:658-667. [DOI: 10.1016/j.ijpharm.2017.05.019] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2017] [Revised: 05/03/2017] [Accepted: 05/09/2017] [Indexed: 11/29/2022]
|
15
|
Pudasaini N, Upadhyay PP, Parker CR, Hagen SU, Bond AD, Rantanen J. Downstream Processability of Crystal Habit-Modified Active Pharmaceutical Ingredient. Org Process Res Dev 2017. [DOI: 10.1021/acs.oprd.6b00434] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Nawin Pudasaini
- Department
of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark
| | - Pratik P. Upadhyay
- Department
of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark
| | | | | | - Andrew D. Bond
- Department
of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark
- Department
of Chemistry, University of Cambridge, Cambridge, U.K
| | - Jukka Rantanen
- Department
of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen, Denmark
| |
Collapse
|
16
|
Juban A, Briançon S, Puel F, Hoc T, Nouguier-Lehon C. Experimental study of tensile strength of pharmaceutical tablets: effect of the diluent nature and compression pressure. EPJ WEB OF CONFERENCES 2017. [DOI: 10.1051/epjconf/201714013002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|